Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2004);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;%Female;Overton;SDG;Country;Region;Publisher;Coverage;Categories;Areas 1;4500151409;"CNS and Neurological Disorders - Drug Targets";journal;"18715273, 19963181";1,554;Q1;96;44;82;6719;372;82;4,54;152,70;34,78;2;0;United Arab Emirates;Middle East;"Bentham Science Publishers B.V.";"2006-2024";"Medicine (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology (Q1)";"Medicine; Neuroscience; Pharmacology, Toxicology and Pharmaceutics" 2;5000153107;"Central Nervous System Agents in Medicinal Chemistry";journal;"18715249, 18756166";0,453;Q3;39;26;48;3037;53;43;1,10;116,81;36,99;1;0;United Arab Emirates;Middle East;"Bentham Science Publishers B.V.";"2006-2023";"Neuropsychology and Physiological Psychology (Q3); Neuroscience (miscellaneous) (Q3); Molecular Medicine (Q4)";"Biochemistry, Genetics and Molecular Biology; Neuroscience; Psychology" 3;130034;"Current Alzheimer Research";journal;"18755828, 15672050";;-;103;36;0;2684;0;0;0,00;74,56;31,34;3;0;United Arab Emirates;Middle East;"Bentham Science Publishers B.V.";"2004-2023";"Neurology; Neurology (clinical)";"Medicine; Neuroscience" 4;14990;"Current Neuropharmacology";journal;"18756190, 1570159X";;-;103;32;0;4283;0;0;0,00;133,84;36,11;1;0;United Arab Emirates;Middle East;"Bentham Science Publishers B.V.";"2004-2023";"Medicine (miscellaneous); Neurology; Neurology (clinical); Pharmacology; Pharmacology (medical); Psychiatry and Mental Health";"Medicine; Neuroscience; Pharmacology, Toxicology and Pharmaceutics" 5;130017;"Current Neurovascular Research";journal;"15672026, 18755739";;-;60;41;0;4148;0;0;0,00;101,17;29,81;2;0;United Arab Emirates;Middle East;"Bentham Science Publishers B.V.";"2004-2023";"Cellular and Molecular Neuroscience; Developmental Neuroscience; Neurology";"Neuroscience"